Improving cancer care and prevention for people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
Clinical trials are testing new ways to prevent and treat cancers, including anal cancer, in people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406613 on NIH RePORTER |
What this research studies
If I join this consortium I could take part in clinical trials that test new treatments and prevention approaches for cancers that affect people with HIV. The program runs at many hospitals and clinics in the U.S., sub-Saharan Africa, and Latin America and works with lab teams to link biological findings to patient trials. Community advocates and a global advisory board help shape the research and outreach so patients' needs are considered. The consortium also collects samples and data that may support future trials and new care options.
Who could benefit from this research
Good fit: Ideal candidates are adults living with HIV who have, or are at increased risk for, cancers studied by the consortium (such as anal cancer) and who can attend a participating clinical site.
Not a fit: People without HIV, those with cancer types not included in the consortium's trials, or those unable to access participating sites are unlikely to benefit directly from this specific program.
Why it matters
Potential benefit: If successful, this work could lower cancer rates, reduce complications, and improve survival and quality of life for people living with HIV.
How similar studies have performed: Yes — the consortium has run many prior trials (over 90) that produced evidence which changed clinical guidelines and improved care for people with HIV-related cancers.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.